Marco Schiavone, Alessio Gasperetti, Paolo Compagnucci, Julia Vogler, Mikael Laredo, Elisabetta Montemerlo, Simone Gulletta, Alexander Breitenstein, Matteo Ziacchi, Martin Martinek, Michela Casella, Pietro Palmisano, Lukas Kaiser, Carlo Lavalle, Leonardo Calò, Sebastian Seidl, Ardan M Saguner, Giovanni Rovaris, Jürgen Kuschyk, Mauro Biffi, Luigi Di Biase, Antonio Dello Russo, Claudio Tondo, Paolo Della Bella, Roland Tilz, Giovanni B Forleo
AIMS: Catheter ablation (CA) of ventricular tachycardia (VT) has become an important tool to improve clinical outcomes in patients with appropriate transvenous implantable cardioverter defibrillator (ICD) shocks. The aim of our analysis was to test whether VT ablation (VTA) impacts long-term clinical outcomes even in subcutaneous ICD (S-ICD) carriers. METHODS AND RESULTS: International Subcutaneous Implantable Cardioverter Defibrillator (iSUSI) registry patients who experienced either an ICD shock or a hospitalization for monomorphic VT were included in this analysis...
March 30, 2024: Europace: European Pacing, Arrhythmias, and Cardiac Electrophysiology